Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Non-Current Deferred Tax Liability (2009 - 2026)

Icon's (ICLR) quarterly Non-Current Deferred Tax Liability came in at $690.3 million in Q2 2026, down 10.93% year-over-year from $775.1 million in Q2 2025, and down 0.58% quarter-over-quarter from $694.3 million in Q1 2026.

Analysis

Icon (ICLR) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Non-Current Deferred Tax Liability for 18 consecutive years, with $690.3 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 10.93% year-over-year to $690.3 million in Q2 2026; TTM through Jun 2026 was $690.3 million, a 10.93% decrease from a year earlier, with the FY2025 full-year figure at $714.4 million, down 11.82% from the prior year.
  • Non-Current Deferred Tax Liability was $690.3 million for Q2 2026 at Icon, down from $694.3 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $1.1 billion in Q1 2022 and troughed at $690.3 million in Q2 2026.
  • A 5-year average of $858.8 million and a median of $856.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • The widest YoY moves for Non-Current Deferred Tax Liability: up 7396.16% in 2022, down 20.71% in 2022.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $987.9 million in 2022, then fell by 9.07% to $898.3 million in 2023, then dropped by 9.81% to $810.2 million in 2024, then retreated by 11.82% to $714.4 million in 2025, then decreased by 3.37% to $690.3 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $690.3 million (Q2 2026), $694.3 million (Q1 2026), and $714.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 690.32 Mn
Mar 31, 2026 694.32 Mn
Dec 31, 2025 714.43 Mn
Sep 30, 2025 744.45 Mn
Jun 30, 2025 775.07 Mn
Mar 31, 2025 788.82 Mn
Dec 31, 2024 810.16 Mn
Sep 30, 2024 818.33 Mn
Jun 30, 2024 843.63 Mn
Mar 31, 2024 869.52 Mn
Dec 31, 2023 898.31 Mn
Sep 30, 2023 883.89 Mn
Jun 30, 2023 934.21 Mn
Mar 31, 2023 957.02 Mn
Dec 31, 2022 987.93 Mn
Sep 30, 2022 974.34 Mn
Jun 30, 2022 1.02 Bn
Mar 31, 2022 1.06 Bn
Dec 31, 2021 1.08 Bn
Sep 30, 2021 1.23 Bn